This site is intended for healthcare professionals

Akebia Therapeutics announces top-line results from its PRO2TECT global phase III program of vadadustat for treatment of anemia due to chronic kidney disease in adult patients not on dialysis.

Read time: 1 mins
Last updated:16th Mar 2021
Published:4th Sep 2020
Condition: Anaemia and CKD
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest